Pengcheng Liu
- Toxicology top 10%
- Biomaterials top 10%
- Molecular Medicine top 10%
-
- Cancer-related molecular mechanisms research 3
- Breast Cancer Treatment Studies 3
-
- Systemic Lupus Erythematosus Research 5
-
- Lung Cancer Treatments and Mutations 4
- Lung Cancer Diagnosis and Treatment 3
-
- Breast Lesions and Carcinomas 2
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Retinal Diseases and Treatments 2
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Pengcheng Liu
36 papers receiving 895 citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Toxicology 30
- Biomaterials 107
- Molecular Medicine 35
- Cancer Research 105
- Drug Discovery 1
Countries citing papers authored by Pengcheng Liu
This map shows the geographic impact of Pengcheng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Liu more than expected).
Fields of papers citing papers by Pengcheng Liu
This network shows the impact of papers produced by Pengcheng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Liu. The network helps show where Pengcheng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengcheng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 18 | |
| 13 | 2022 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2022 | 4 | |
| 16 | 2020 | 6 | |
| 17 | 2019 | 0 | |
| 18 | 2018 | 13 | |
| 19 | 2014 | 11 | |
| 20 | 2008 | 4 |
About Pengcheng Liu
Pengcheng Liu is a scholar working on Microbiology, Structural Biology and Cancer Research, having authored 43 papers that have together received 909 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (5 papers), Lung Cancer Treatments and Mutations (4 papers), Lung Cancer Diagnosis and Treatment (3 papers), Cancer-related molecular mechanisms research (3 papers), Breast Cancer Treatment Studies (3 papers), Breast Lesions and Carcinomas (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Retinal Diseases and Treatments (2 papers). The work is most often cited by research in Toxicology (30 citations), Biomaterials (107 citations) and Molecular Medicine (35 citations). Pengcheng Liu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Kuan Liu, Liu R, Xing Wu, Ming Cai, Li Wei, Jin Qi, Lianfu Deng, Rui Wu, Jinshen Wang and Kazunori Mizuno.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.